The biology of desmin filaments: how do mutations affect their structure, assembly, and organisation?

scientific article

The biology of desmin filaments: how do mutations affect their structure, assembly, and organisation? is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1016/J.JSB.2004.04.003
P698PubMed publication ID15477095
P5875ResearchGate publication ID8239126

P50authorUeli AebiQ14594735
P2093author name stringHarald Herrmann
Sergei V Strelkov
Harald Bär
Gunnar Sjöberg
P433issue2
P304page(s)137-152
P577publication date2004-11-01
P1433published inJournal of Structural BiologyQ3186947
P1476titleThe biology of desmin filaments: how do mutations affect their structure, assembly, and organisation?
P478volume148

Reverse relations

cites work (P2860)
Q43184436A missense mutation in desmin tail domain linked to human dilated cardiomyopathy promotes cleavage of the head domain and abolishes its Z-disc localization.
Q24602132A novel custom resequencing array for dilated cardiomyopathy
Q51918460A quantitative kinetic model for the in vitro assembly of intermediate filaments from tetrameric vimentin.
Q64376893Aberrant Mitochondrial Fission Is Maladaptive in Desmin Mutation-Induced Cardiac Proteotoxicity
Q92341308Alterations of redox dynamics and desmin post-translational modifications in skeletal muscle models of desminopathies
Q45884628Angiogenic gene-modified myoblasts promote vascularization during repair of skeletal muscle defects
Q35685364Arsenic exposure to killifish during embryogenesis alters muscle development
Q37313697Build it up-Tear it down: protein quality control in the cardiac sarcomere
Q84060258Cardiac conduction disturbances and differential effects on atrial and ventricular electrophysiological properties in desmin deficient mice
Q36553090Clinical and myopathological characteristics of desminopathy caused by a mutation in desmin tail domain
Q53457776Comparative Label-Free Mass Spectrometric Analysis of Mildly versus Severely Affected mdx Mouse Skeletal Muscles Identifies Annexin, Lamin, and Vimentin as Universal Dystrophic Markers.
Q52313732Comparative gel-based proteomic analysis of chemically crosslinked complexes in dystrophic skeletal muscle.
Q90353690Complex Correlations Between Desmin Content, Myofiber Types, and Innervation Patterns in the Human Extraocular Muscles
Q90795283Condensed desmin and actin cytoskeletal communication in lipid droplets
Q90076081Consistent expression pattern of myogenic regulatory factors in whole muscle and isolated human muscle satellite cells after eccentric contractions in humans
Q79554774Conspicuous involvement of desmin tail mutations in diverse cardiac and skeletal myopathies
Q38801420Desmin Mutation in the C-Terminal Domain Impairs Traction Force Generation in Myoblasts
Q36677507Desmin mediates TNF-alpha-induced aggregate formation and intercalated disk reorganization in heart failure.
Q35395372Desmin-related cardiomyopathy: an unfolding story
Q36503373Desminopathies: pathology and mechanisms
Q38206258Desmosomes in the heart: a review of clinical and mechanistic analyses
Q42252285Disassembly of myofibrils and potential imbalanced forces on Z-discs in cultured adult cardiomyocytes.
Q39798059Disease mutations in the "head" domain of the extra-sarcomeric protein desmin distinctly alter its assembly and network-forming properties
Q24627911Dual color photoactivation localization microscopy of cardiomyopathy-associated desmin mutants
Q34457002Essential role of obscurin in cardiac myofibrillogenesis and hypertrophic response: evidence from small interfering RNA-mediated gene silencing.
Q83227151Evolutionary loss of foot muscle during development with characteristics of atrophy and no evidence of cell death
Q41504807Flow birefringence property of desmin filaments
Q40308202Forced expression of desmin and desmin mutants in cultured cells: impact of myopathic missense mutations in the central coiled-coil domain on network formation.
Q42736271Head and rod 1 interactions in vimentin: identification of contact sites, structure, and changes with phosphorylation using site-directed spin labeling and electron paramagnetic resonance
Q30299996Improved neurological outcome by intramuscular injection of human amniotic fluid derived stem cells in a muscle denervation model
Q39837470Interference of amino-terminal desmin fragments with desmin filament formation
Q37419742Intermediate filament diseases: desminopathy.
Q37241400Intermediate filaments: primary determinants of cell architecture and plasticity
Q59792842Intra-amniotic Sildenafil Treatment Modulates Vascular Smooth Muscle Cell Phenotype in the Nitrofen Model of Congenital Diaphragmatic Hernia
Q89862507Is Desmin Propensity to Aggregate Part of its Protective Function?
Q57753190Lasp-2 expression, localization, and ligand interactions: a new Z-disc scaffolding protein
Q28295898Mechanistic basis of desmosome-targeted diseases
Q34070196Metallothionein as a clonable high-density marker for cryo-electron microscopy
Q37258743Molecular pathology of myofibrillar myopathies.
Q30478290Monitoring intermediate filament assembly by small-angle x-ray scattering reveals the molecular architecture of assembly intermediates
Q24313412Myotubularin controls desmin intermediate filament architecture and mitochondrial dynamics in human and mouse skeletal muscle
Q28533968N-acetyl-L-cysteine prevents stress-induced desmin aggregation in cellular models of desminopathy
Q30832463Nebulette is a powerful cytolinker organizing desmin and actin in mouse hearts
Q36884249Primary desminopathies
Q33450135Proteomics identification of desmin as a potential oncofetal diagnostic and prognostic biomarker in colorectal cancer
Q35942142Recurrent and founder mutations in the Netherlands: the cardiac phenotype of DES founder mutations p.S13F and p.N342D.
Q45880234Satellite cell number and cell cycle kinetics in response to acute myotrauma in humans: immunohistochemistry versus flow cytometry
Q34075709Severe muscle disease-causing desmin mutations interfere with in vitro filament assembly at distinct stages
Q52889077Teratoma formation of human embryonic stem cells in three-dimensional perfusion culture bioreactors.
Q48190393The MTM1-UBQLN2-HSP complex mediates degradation of misfolded intermediate filaments in skeletal muscle.
Q33679100The role of muscle cells in regulating cartilage matrix production.
Q24633116The tumor inhibitor and antiangiogenic agent withaferin A targets the intermediate filament protein vimentin
Q35148384Tissue specific dysregulated protein subnetworks in type 2 diabetic bladder urothelium and detrusor muscle
Q40758276Tissue-engineered artificial oesophagus patch using three-dimensionally printed polycaprolactone with mesenchymal stem cells: a preliminary report
Q37241396Tragedy in a heartbeat: malfunctioning desmin causes skeletal and cardiac muscle disease
Q34776342Two desmin gene mutations associated with myofibrillar myopathies in Polish families
Q40251775Variable pathogenic potentials of mutations located in the desmin alpha-helical domain.
Q34395548Vimentin as an integral regulator of cell adhesion and endothelial sprouting
Q36220005Voltage-Dependent Anion Channel 1(VDAC1) Participates the Apoptosis of the Mitochondrial Dysfunction in Desminopathy
Q40765741Vps34 regulates myofibril proteostasis to prevent hypertrophic cardiomyopathy
Q33748201Withaferin A targets intermediate filaments glial fibrillary acidic protein and vimentin in a model of retinal gliosis
Q33779909αB-crystallin is a sensor for assembly intermediates and for the subunit topology of desmin intermediate filaments.

Search more.